Aim Immunotech Inc (AIM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,705 | -17,320 | -11,353 | -7,653 | -5,817 |
| Depreciation Amortization | 457 | 595 | 460 | 389 | 131 |
| Accounts payable and accrued liabilities | 561 | -60 | -179 | -988 | 124 |
| Other Working Capital | 790 | 296 | -1,119 | -1,504 | 766 |
| Other Operating Activity | -464 | 1,601 | 1,258 | 1,933 | -19 |
| Operating Cash Flow | $-2,361 | $-14,888 | $-10,933 | $-7,823 | $-4,815 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 954 | 5,262 | 1,439 | 947 | -108 |
| PPE Investments | N/A | -18 | -18 | N/A | N/A |
| Purchase Sale Intangibles | -56 | -538 | -419 | -279 | -50 |
| Other Investing Activity | -56 | -538 | -419 | -279 | -50 |
| Investing Cash Flow | $898 | $4,706 | $1,002 | $668 | $-158 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 2,047 | N/A | N/A |
| Debt Issued | N/A | 2,500 | 2,500 | 2,367 | 2,500 |
| Debt Repayment | N/A | -251 | N/A | N/A | N/A |
| Common Stock Issued | 660 | 4,195 | 860 | 856 | 329 |
| Common Stock Repurchased | N/A | N/A | N/A | 2,047 | N/A |
| Financing Cash Flow | $660 | $6,444 | $5,407 | $5,270 | $2,829 |
| Beginning Cash Position | 1,701 | 5,439 | 5,439 | 5,439 | 5,439 |
| End Cash Position | 898 | 1,701 | 915 | 3,554 | 3,295 |
| Net Cash Flow | $-803 | $-3,738 | $-4,524 | $-1,885 | $-2,144 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,361 | -14,888 | -10,933 | -7,823 | -4,815 |
| Capital Expenditure | N/A | -18 | -18 | N/A | N/A |
| Free Cash Flow | -2,361 | -14,906 | -10,951 | -7,823 | -4,815 |